{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:36:14Z","timestamp":1786718174501,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Endocr Metab"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/ijem.ijem_193_17","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T01:41:27Z","timestamp":1505439687000},"page":"781","source":"Crossref","is-referenced-by-count":3,"title":["Management of primary adrenal insufficiency: Review of current clinical practice in a developed and a developing country"],"prefix":"10.4103","volume":"21","author":[{"given":"OmJ","family":"Lakhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2230-8210.214780-1","first-page":"369","volume-title":"Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency","author":"Nilsson","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.214780-2","first-page":"167","volume-title":"Therapeutic management of adrenal insufficiency","author":"Hahner","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key-10.4103\/2230-8210.214780-3","first-page":"104","volume-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"key":"key-10.4103\/2230-8210.214780-4","first-page":"21","volume-title":"What is the best long-term management strategy for patients with primary adrenal insufficiency?","author":"Quinkler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/2230-8210.214780-5","first-page":"R165","volume-title":"Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: Clinical insights from across Europe","author":"Grossman","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/2230-8210.214780-6","unstructured":"The Addison's Disease Self-Help Group. The UK and Ireland Support Group for People with Addison's Disease (Adrenal Insufficiency) and Their Families; 2017. Available from: http:\/\/www.addisons.org.uk\/index.php\/articles.html\/_\/about-the-adshg. [Last accessed on 2017 Feb 25]."},{"key":"key-10.4103\/2230-8210.214780-7","unstructured":"Treanor J, Davis N. Drugs Firms Face Fresh Questions after Actavis Accused of 12,000% Price Hike. The Guardian; 2016. Available from: https:\/\/www.theguardian.com\/business\/2016\/dec\/16\/watchdog-accuses-actavis-hiking-price-lifesaving-drug-hydrocortisone. [Last accessed on 10 March 2017]."},{"key":"key-10.4103\/2230-8210.214780-8","first-page":"40","volume-title":"European Adrenal Insufficiency Registry (EU-AIR): A comparative observational study of glucocorticoid replacement therapy","author":"Ekman","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"key-10.4103\/2230-8210.214780-9","unstructured":"AdisInsight. Hydrocortisone- Diurnal; 2017. Available from: http:\/\/www.adisinsight.springer.com\/drugs\/800028491. [Last accessed on 2017 Feb 26]."},{"key":"key-10.4103\/2230-8210.214780-10","unstructured":"Dorset Medicines Advisory Group. Commissioning Statement on the Use of Modified Release Hydrocortisone (Plenadren) for the Treatment of Adrenal Insufficiency; 2016. Available from: http:\/\/www.dorsetccg.nhs.uk\/Downloads\/aboutus\/medicines-management\/Other%20Guidelines\/Plenadren%20comissioning%20statement%20revised%20draft.pdf. [Last accessed on 2017 Feb 26]."},{"key":"key-10.4103\/2230-8210.214780-11","first-page":"116","volume-title":"Levothyroxine replacement before glucocorticoid replacement leading to adrenal crisis in a case of autoimmune polyendocrine syndrome type II (Schmidt syndrome)","author":"Lakhani","year":"2015","journal-title":"Thyroid Res Pract","ISSN":"https:\/\/id.crossref.org\/issn\/0973-0354","issn-type":"print"},{"key":"key-10.4103\/2230-8210.214780-12","first-page":"320","volume-title":"Intramuscular ACTH stimulation test for assessment of adrenal function","author":"Gundgurthi","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/2230-8210.214780-13","first-page":"554","volume-title":"An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure","author":"Whitaker","year":"2014","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:32:00Z","timestamp":1786714320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.IJEM_193_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"alternative-id":["214780"],"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_193_17","relation":{},"ISSN":["2230-8210"],"issn-type":[{"value":"2230-8210","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}